19 Jan 2026Open access
Bevacizumab in Advanced High Grade Serous Ovarian Cancer: The Impact of BRCA Mutation StatusPublisher siteJournal of cancer research updates, PARP inhibition in cancer therapy
Active, last published 2026
In ovarian cancer diagnosis and treatment
Asmaa Mohamed
Elkady
Scholar“Research focused on Ovarian cancer diagnosis and treatment and adjacent fields.”
Claim Your Profile0
H-index
0
Citations
Asmaa has not officially claimed their profile. If you are Asmaa, claim it free.
Claim Your Profile
Pioneer
LOCKED
Pathfinder
LOCKED
Scholar
EARNED
Innovator
LOCKED
Inventor
LOCKED
Catalyst
LOCKED
Expert
UPGRADE
01 · About the work
What I study
smaa Mohamed Elkady is a researcher working on Ovarian cancer diagnosis and treatment. A fuller summary will appear once they update their profile.
02 · Reach
Publication output and reach
Asmaa's work has been cited 0 times across 1 active year. Bars show publications per year; the line shows cumulative citation totals across publications first appearing in each year.
03 · Research focus
Topics
Ovarian cancer diagnosis and treatment×2PARP inhibition in cancer therapy×2
04 · Where I am
Affiliations
Affiliation on published researchTanta University, EgyptDrawn from the institution listed on this researcher’s published work.
Research themes (UN SDGs)
05 · Selected work
Recent publications
1 workExpert Academic Profiles go further
Citation trend analytics, exportable publication records, and direct enquiry routing from industry and funders.
Are you Asmaa?
Claim it to verify your details, connect with industry partners, and explore Fractional Domain Expert opportunities through MARATTO™.
African researchers are full of potential that too often goes unrecognised. Your MARATTO™ profile gives your work the commercial pathway it deserves.
Claim Your Profile
Free to claim · takes a minute to verify it’s you